Stocking HA fillers when the specs don't line up

Every clinic that stocks hyaluronic acid fillers ends up with more of them than it planned to. The range starts with two or three. A rep introduces a fourth. An injector prefers something particular for one indication. Within a couple of years the fridge holds eight products that nobody in the building can rank against each other, and reducing that number is hard, because the information you would need to prove two of them are interchangeable is not published in a form that lets you compare them.

What varies, in general terms

HA fillers are not one material. They differ in how the hyaluronic acid is crosslinked — the chemistry used, how much of it, and how the process is run — and in what that produces: a gel that is firmer or softer, more or less cohesive, more or less resistant as it goes through a given needle. Some are described as smooth and homogeneous, others as particulate. Those differences are real, and they are why a range exists at all rather than a single product.

What follows from that is less obvious. Two products from different manufacturers can be built to sit in the same part of a range and still behave differently. Two products described in similar words can be built very differently. The description is not the specification.

The published numbers don't settle it

Manufacturers do publish attributes. They do not publish the same attributes, and they do not measure them the same way. Rheological figures depend on the instrument, the test conditions and the temperature they were run at; unless the method is published alongside the number, a value from one company's technical literature and a value from another's are not on the same scale, however similar the units look. Vocabulary drifts too. Terms describing gel structure are used differently by different companies, and none of them is a standard you can hold two brands to.

That is not a reason to ignore published data. It is a reason to treat it as a description of a product rather than a score in a league table. Where a specific figure matters to a decision you are making, the authoritative source is the manufacturer's instructions for use and the documentation that arrives with the batch — not a comparison chart, including ours.

Why the shelf grows

For a buyer, the practical consequence is range creep. Each manufacturer's range is internally coherent: the products are designed to differ from one another in a way the manufacturer can explain. Buy across three manufacturers and you hold three internally coherent ranges laid on top of each other, with overlaps nobody has audited. The overlap is where the money sits — capital in the fridge, product ageing towards its expiry date, and injectors reaching for whatever is nearest to hand.

Variants multiply it without anyone deciding to. Ranges are commonly offered in more than one pack size, and often in versions with and without an anaesthetic, so a range of four products is really eight or twelve order lines — each with its own turnover, its own reorder point and its own expiry date.

An audit worth doing before the next order

This takes about an hour and it is the only reliable way to find out how many products the clinic uses, as distinct from how many it owns.

• List every HA filler on the shelf: brand, reference, pack size, variant and the date it expires.
• Next to each one, write in plain words the indication your team actually reaches for it for. Two products with the same sentence are one product you are paying twice to hold.
• Mark anything that has not moved in a quarter.
• Mark anything bought as a trial that never became routine.
• Mark anything only one injector uses. When that person is on leave it is dead stock for a fortnight.
• Sort by expiry date and ask whether current demand will consume the earliest-dated items inside their window.
• Note anywhere you hold a single unit of something a clinic day cannot run without. That is a stock-out waiting to happen, not a lean range.

What usually comes out of it is a short list of products the clinic genuinely relies on, a longer list held out of habit, and one or two gaps nobody had noticed because a substitute was always within reach.

What to ask before adding a line

The questions that decide whether a new product belongs on the shelf are supply questions rather than product ones. How consistently is that exact reference available. What expiry window arrives on a typical delivery. Is the IFU in the box. What documentation accompanies the batch, and how quickly can it be produced if someone asks for it later. What happens if a delivery arrives outside the condition it should have been shipped in. A product you cannot reliably reorder in eight weeks is not a range addition — it is a one-off you will end up substituting anyway.

Where a comparison view helps

Lining products up side by side is still worth doing. It just answers a narrower question than it appears to. The store's comparison tool puts up to four products next to each other using the attributes their manufacturers publish, and it can hide the rows where every product agrees so that what is left is the differences. Where a field is blank, that means nothing was published for it — not that the answer is nothing.

That is genuinely useful for narrowing a shortlist, and for showing whoever signs off the order why two products are on it rather than five. It cannot tell you the two are equivalent, and no side-by-side view from any supplier can.

The number of HA fillers a clinic needs is set by what it treats and who is injecting, not by how many exist. Most ranges are larger than the practice they serve. Finding out by how much means looking at the shelf, not the catalogue.